Levine MD, Wang H, Sriram B, Khan A, et al. Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance. Gynecol Oncol 2024;182:51-56.
PMID: 38262238